Listed

Instil Bio, Inc.

TILNasdaqCIK 1789769HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$5.6m, Q2 FY2026
Net income−$4.3m, Q2 FY2026
Instil Bio, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m8.5Research and development, Q3 FY2023, three months to 2023-09-30$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure2.0Research and development, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-03-21, accession 0001789769-24-000036. Derived: 12-month figure less the 9-month figure.Report this figure7.3Research and development, Q1 FY2024, three months to 2024-03-31$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure2.9Research and development, Q2 FY2024, three months to 2024-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(66.7)Operating income, Q3 FY2023, three months to 2023-09-30−$66.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure(13.0)Operating income, Q4 FY2023, three months to 2023-12-31−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-04, accession 0001789769-25-000017. Derived: 12-month figure less the 9-month figure.Report this figure(24.0)Operating income, Q1 FY2024, three months to 2024-03-31−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure(14.1)Operating income, Q2 FY2024, three months to 2024-06-30−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure(23.6)Operating income, Q3 FY2024, three months to 2024-09-30−$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(11.8)Operating income, Q4 FY2024, three months to 2024-12-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(30.6)Operating income, Q1 FY2025, three months to 2025-03-31−$30.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(23.4)Operating income, Q2 FY2025, three months to 2025-06-30−$23.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(15.0)Operating income, Q3 FY2025, three months to 2025-09-30−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(9.6)Operating income, Q4 FY2025, three months to 2025-12-31−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Operating income, Q1 FY2026, three months to 2026-03-31−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(5.6)Operating income, Q2 FY2026, three months to 2026-06-30−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Interest expense$m2.0Interest expense, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure2.0Interest expense, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-21, accession 0001789769-24-000036. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure2.0Interest expense, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure2.0Interest expense, Q3 FY2024, three months to 2024-09-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure3.0Interest expense, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure1.6Interest expense, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure1.6Interest expense, Q3 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure1.6Interest expense, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure1.6Interest expense, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure1.6Interest expense, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-21, accession 0001789769-24-000036. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(67.4)Net income, Q3 FY2023, three months to 2023-09-30−$67.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure(12.9)Net income, Q4 FY2023, three months to 2023-12-31−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-04, accession 0001789769-25-000017. Derived: 12-month figure less the 9-month figure.Report this figure(24.3)Net income, Q1 FY2024, three months to 2024-03-31−$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(14.9)Net income, Q2 FY2024, three months to 2024-06-30−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(23.0)Net income, Q3 FY2024, three months to 2024-09-30−$23.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(11.9)Net income, Q4 FY2024, three months to 2024-12-31−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(28.2)Net income, Q1 FY2025, three months to 2025-03-31−$28.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(21.4)Net income, Q2 FY2025, three months to 2025-06-30−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(13.6)Net income, Q3 FY2025, three months to 2025-09-30−$13.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure(8.2)Net income, Q4 FY2025, three months to 2025-12-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Net income, Q1 FY2026, three months to 2026-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(4.3)Net income, Q2 FY2026, three months to 2026-06-30−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Diluted EPS$ per share(10.37)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$10.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figurenot reported(3.74)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$3.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure(2.29)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure(3.54)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figurenot reported(4.32)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$4.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(3.24)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$3.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(2.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$2.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figurenot reported(0.62)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(0.63)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Basic EPS$ per share(10.37)Basic EPS, Q3 FY2023, three months to 2023-09-30−$10.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figurenot reported(3.74)Basic EPS, Q1 FY2024, three months to 2024-03-31−$3.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure(2.29)Basic EPS, Q2 FY2024, three months to 2024-06-30−$2.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure(3.54)Basic EPS, Q3 FY2024, three months to 2024-09-30−$3.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figurenot reported(4.32)Basic EPS, Q1 FY2025, three months to 2025-03-31−$4.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(3.24)Basic EPS, Q2 FY2025, three months to 2025-06-30−$3.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure(2.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$2.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figurenot reported(0.62)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(0.63)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure

Balance sheet

Cash and equivalents$5.5m, Q2 FY2026
Shareholders' equity$107.4m, Q2 FY2026
Instil Bio, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.1Cash and equivalents, Q3 FY2023, at 2023-09-30$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure9.2Cash and equivalents, FY2023, at 2023-12-31$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-04, accession 0001789769-25-000017.Report this figure5.5Cash and equivalents, Q1 FY2024, at 2024-03-31$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure6.8Cash and equivalents, Q2 FY2024, at 2024-06-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure6.7Cash and equivalents, Q3 FY2024, at 2024-09-30$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure8.8Cash and equivalents, FY2024, at 2024-12-31$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure15.4Cash and equivalents, Q1 FY2025, at 2025-03-31$15.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure7.7Cash and equivalents, Q2 FY2025, at 2025-06-30$7.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure5.8Cash and equivalents, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure6.6Cash and equivalents, FY2025, at 2025-12-31$6.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure5.0Cash and equivalents, Q1 FY2026, at 2026-03-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure5.5Cash and equivalents, Q2 FY2026, at 2026-06-30$5.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Current assets$m196Current assets, Q3 FY2023, at 2023-09-30$195.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure161Current assets, FY2023, at 2023-12-31$160.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-04, accession 0001789769-25-000017.Report this figure161Current assets, Q1 FY2024, at 2024-03-31$161.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure155Current assets, Q2 FY2024, at 2024-06-30$154.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure133Current assets, Q3 FY2024, at 2024-09-30$132.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure124Current assets, FY2024, at 2024-12-31$124.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure219Current assets, Q1 FY2025, at 2025-03-31$219.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure207Current assets, Q2 FY2025, at 2025-06-30$207.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure196Current assets, Q3 FY2025, at 2025-09-30$196.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure191Current assets, FY2025, at 2025-12-31$191.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure188Current assets, Q1 FY2026, at 2026-03-31$188.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure71.6Current assets, Q2 FY2026, at 2026-06-30$71.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Total assets$m340Total assets, Q3 FY2023, at 2023-09-30$340.3m. XBRL concept us-gaap:Assets. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure326Total assets, FY2023, at 2023-12-31$325.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-04, accession 0001789769-25-000017.Report this figure306Total assets, Q1 FY2024, at 2024-03-31$306.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure294Total assets, Q2 FY2024, at 2024-06-30$294.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure273Total assets, Q3 FY2024, at 2024-09-30$272.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure264Total assets, FY2024, at 2024-12-31$263.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure237Total assets, Q1 FY2025, at 2025-03-31$237.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure231Total assets, Q2 FY2025, at 2025-06-30$231.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure212Total assets, Q3 FY2025, at 2025-09-30$211.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure204Total assets, FY2025, at 2025-12-31$203.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure200Total assets, Q1 FY2026, at 2026-03-31$200.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure198Total assets, Q2 FY2026, at 2026-06-30$197.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Current liabilities$m13.5Current liabilities, Q3 FY2023, at 2023-09-30$13.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure10.6Current liabilities, FY2023, at 2023-12-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-04, accession 0001789769-25-000017.Report this figure11.4Current liabilities, Q1 FY2024, at 2024-03-31$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure10.3Current liabilities, Q2 FY2024, at 2024-06-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure10.3Current liabilities, Q3 FY2024, at 2024-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure7.9Current liabilities, FY2024, at 2024-12-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure7.2Current liabilities, Q1 FY2025, at 2025-03-31$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure13.9Current liabilities, Q2 FY2025, at 2025-06-30$13.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure5.7Current liabilities, Q3 FY2025, at 2025-09-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure4.8Current liabilities, FY2025, at 2025-12-31$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure4.7Current liabilities, Q1 FY2026, at 2026-03-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure3.3Current liabilities, Q2 FY2026, at 2026-06-30$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Total liabilities$m106Total liabilities, Q3 FY2023, at 2023-09-30$106.2m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure99.8Total liabilities, FY2023, at 2023-12-31$99.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-04, accession 0001789769-25-000017.Report this figure100Total liabilities, Q1 FY2024, at 2024-03-31$100.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure99.3Total liabilities, Q2 FY2024, at 2024-06-30$99.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure96.2Total liabilities, Q3 FY2024, at 2024-09-30$96.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure94.1Total liabilities, FY2024, at 2024-12-31$94.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure92.5Total liabilities, Q1 FY2025, at 2025-03-31$92.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure99.3Total liabilities, Q2 FY2025, at 2025-06-30$99.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure91.3Total liabilities, Q3 FY2025, at 2025-09-30$91.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure89.7Total liabilities, FY2025, at 2025-12-31$89.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure89.7Total liabilities, Q1 FY2026, at 2026-03-31$89.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure90.3Total liabilities, Q2 FY2026, at 2026-06-30$90.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure
Shareholders' equity$m234Shareholders' equity, Q3 FY2023, at 2023-09-30$234.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure226Shareholders' equity, FY2023, at 2023-12-31$225.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001789769-26-000019.Report this figure206Shareholders' equity, Q1 FY2024, at 2024-03-31$205.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure195Shareholders' equity, Q2 FY2024, at 2024-06-30$195.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure176Shareholders' equity, Q3 FY2024, at 2024-09-30$176.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure169Shareholders' equity, FY2024, at 2024-12-31$169.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure145Shareholders' equity, Q1 FY2025, at 2025-03-31$144.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure132Shareholders' equity, Q2 FY2025, at 2025-06-30$131.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure120Shareholders' equity, Q3 FY2025, at 2025-09-30$120.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure114Shareholders' equity, FY2025, at 2025-12-31$113.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure111Shareholders' equity, Q1 FY2026, at 2026-03-31$110.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure107Shareholders' equity, Q2 FY2026, at 2026-06-30$107.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure

Cash flow

Operating cash flow−$4.6m, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Instil Bio, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(14.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001789769-24-000103. Derived: 9-month figure less the 6-month figure.Report this figure(13.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-04, accession 0001789769-25-000017. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure(10.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001789769-25-000081. Derived: 6-month figure less the 3-month figure.Report this figure(20.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001789769-25-000094. Derived: 9-month figure less the 6-month figure.Report this figure(10.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(14.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001789769-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure(10.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001789769-25-000094. Derived: 9-month figure less the 6-month figure.Report this figure(7.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001789769-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure(4.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001789769-26-000057. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m5.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001789769-24-000103. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-04, accession 0001789769-25-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-13, accession 0001789769-24-000086. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001789769-24-000103. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-04, accession 0001789769-25-000017. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)6.78m, Q2 FY2026
Instil Bio, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares130Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30129,680,217 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2023-11-13, accession 0001789769-23-000093.Report this figure6.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-316,503,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001789769-24-000059.Report this figure6.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-306,503,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001789769-24-000086.Report this figure6.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-306,503,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001789769-24-000103.Report this figure6.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-316,503,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001789769-25-000051.Report this figure6.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-306,503,913 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001789769-25-000081.Report this figure6.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-306,506,681 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure6.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-316,532,658 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure6.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-306,596,975 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure6.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-306,757,742 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001789769-25-000094.Report this figure6.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-316,781,976 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001789769-26-000045.Report this figure6.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-306,781,976 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure

Shares outstanding: 6.78mShares outstanding, period not labelled, at 2026-08-116,781,976 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001789769-26-000057.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.